The Potential Effect of the IDH1 Mutation and MGMT Gene Promoter Methylation on the Control of Glioblastoma-Associated Epilepsy in Patients Receiving Anti-Epileptic Agents and Chemotherapies

Objectives:(a) The objective of the study was to assess the control of seizure in glioblastoma patients receiving anti-epileptic drugs and chemotherapies after total resection and its association with O-methylguanine-DNA methyltransferase (MGMT) promoter methylation and the isocitrate dehydrogenase...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Maher KURDI, Nadeem Shafique BUTT, Saleh BAEESA, Badrah ALGHAMDI, Yazid MAGHRABI, Anas BARDEESI, Rothaina SAEEDI, Fahad ALGHAMDI, Najla ALGHANMI, Mohammed BARI, Alaa SAMKARI, Ahmed LARY, Taghreed ALSINANI, Sahar HAKAMY
التنسيق: Artigo
اللغة:Inglês
منشور في: Turkish Epilepsy Society 2021-09-01
سلاسل:Archives of Epilepsy
الموضوعات:
anti-epileptic drugs
epilepsy
glioblastoma
idh1 mutation
mgmt promotor methylation
temozolomide
الوصول للمادة أونلاين: http://archepilepsy.org/archives/archive-detail/article-preview/the-potential-effect-of-the-dh1-mutation-and-mgmt-/54631
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة